FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Abbott Laboratories Zemplar Recall

Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx…

Abbott Laboratories · Abbott Park, IL

Risk level
Class II
Reported by FDA
Jun 27, 2012
Recall ID
D-1388-2012
Check your lot numberHow we source this data

Summary

Abbott Laboratories recalled Zemplar starting May 14, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1388-2012 on Jun 27, 2012. Reason: CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection. Status: Terminated.

Why it was recalled

CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.

Product description

Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05

Lot numbers, UPCs & expiration codes

Lot #: 11-122-DK, Exp 10/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1388-2012
Classification
Class II
Status
Terminated
Recall initiated
May 14, 2012
FDA report date
Jun 27, 2012
Quantity
121,000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Abbott Laboratories

Original FDA data

Every field from FDA enforcement report D-1388-2012, exactly as published.

Show all FDA fields
City
Abbott Park
State
IL
Status
Terminated
Country
United States
Event ID
61878
Address
100 Abbott Park Rd
Code information
Lot #: 11-122-DK, Exp 10/13
Postal code
60064-3502
Report date
Jun 27, 2012
Product type
Drugs
Recall number
D-1388-2012
Classification
Class II
Recalling firm
Abbott Laboratories
Product quantity
121,000 vials
Termination date
Dec 3, 2012
Reason for recall
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05
Distribution pattern
Nationwide
Recall initiation date
May 14, 2012
Initial firm notification
Letter
Center classification date
Jun 18, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1388-2012, published Jun 27, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls